Woodline Partners »

Petiq shares owned by Woodline Partners

Quarter-by-quarter ownership of Petiq (PETQ) shares owned by Woodline Partners from 13F filings

Historical chart of Woodline Partners investment in Petiq

Tip: Access up to 7 years of quarterly data

All positions including Petiq held by Woodline Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Petiq by Woodline Partners

Quarter filed Position value Share count Share price at filing
2024-09-30 $21M 680k 30.77

More positions owned by Woodline Partners

Meta Platforms Cl A (META)
Gilead Sciences (GILD)
Abbvie (ABBV)
Revolution Medicines (RVMD)
Vaxcyte (PCVX)
Asml Holding N V N Y Registry Shs (ASML)
Nuvalent Inc-a (NUVL)
Permian Resources Corp Class A Com (PR)
Encana Corporation (OVV)
Keysight Technologies (KEYS)
Danaher Corporation (DHR)
Aon Shs Cl A (AON)
Stmicroelectronics N V Ny Registry (STM)
Regeneron Pharmaceuticals (REGN)
EQT Corporation (EQT)

View all positions for Woodline Partners

Top funds holding Petiq

BlackRock
BlackRock
Vanguard Group
Glazer Capital
Eos Management
Aristotle Capital Boston
D. E. Shaw & Co
Vivaldi Asset Management
Highland Capital Management Fund Advisors
Woodline Partners
Alpine Associates Management
Pentwater Capital Management
Geode Capital Management
State Street Corporation
Gabelli Funds

View all funds holding Petiq